- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Non-Invasive Liquid Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Non-Invasive Liquid Biopsy size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Non-Invasive Liquid Biopsy market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Non-Invasive Liquid Biopsy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Stool Test
Urine Test
Saliva Test
Others
Market segment by Application, can be divided into
Hospital
Laboratory
Others
Market segment by players, this report covers
Bio-Techne
Endress+Hauser
Exact Sciences Corporation
Lonza Group AG
MDxHealth
Merck KGaA
MutantDx
Norgen Biotek Corp
Nucleix
Oasis Diagnostics Corporation
OraSure Technologies
PerkinElmer
Predicine
Qiagen
Thermo Fisher Scientific
Zymo Research Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Non-Invasive Liquid Biopsy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Non-Invasive Liquid Biopsy, with revenue, gross margin and global market share of Non-Invasive Liquid Biopsy from 2019 to 2021.
Chapter 3, the Non-Invasive Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Non-Invasive Liquid Biopsy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Non-Invasive Liquid Biopsy research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Non-Invasive Liquid Biopsy
1.2 Classification of Non-Invasive Liquid Biopsy by Type
1.2.1 Overview: Global Non-Invasive Liquid Biopsy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Non-Invasive Liquid Biopsy Revenue Market Share by Type in 2020
1.2.3 Stool Test
1.2.4 Urine Test
1.2.5 Saliva Test
1.2.6 Others
1.3 Global Non-Invasive Liquid Biopsy Market by Application
1.3.1 Overview: Global Non-Invasive Liquid Biopsy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Global Non-Invasive Liquid Biopsy Market Size & Forecast
1.5 Global Non-Invasive Liquid Biopsy Market Size and Forecast by Region
1.5.1 Global Non-Invasive Liquid Biopsy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Non-Invasive Liquid Biopsy Market Size by Region, (2016-2021)
1.5.3 North America Non-Invasive Liquid Biopsy Market Size and Prospect (2016-2026)
1.5.4 Europe Non-Invasive Liquid Biopsy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Non-Invasive Liquid Biopsy Market Size and Prospect (2016-2026)
1.5.6 South America Non-Invasive Liquid Biopsy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Non-Invasive Liquid Biopsy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-Invasive Liquid Biopsy Market Drivers
1.6.2 Non-Invasive Liquid Biopsy Market Restraints
1.6.3 Non-Invasive Liquid Biopsy Trends Analysis
2 Company Profiles
2.1 Bio-Techne
2.1.1 Bio-Techne Details
2.1.2 Bio-Techne Major Business
2.1.3 Bio-Techne Non-Invasive Liquid Biopsy Product and Solutions
2.1.4 Bio-Techne Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bio-Techne Recent Developments and Future Plans
2.2 Endress+Hauser
2.2.1 Endress+Hauser Details
2.2.2 Endress+Hauser Major Business
2.2.3 Endress+Hauser Non-Invasive Liquid Biopsy Product and Solutions
2.2.4 Endress+Hauser Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Endress+Hauser Recent Developments and Future Plans
2.3 Exact Sciences Corporation
2.3.1 Exact Sciences Corporation Details
2.3.2 Exact Sciences Corporation Major Business
2.3.3 Exact Sciences Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.3.4 Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Exact Sciences Corporation Recent Developments and Future Plans
2.4 Lonza Group AG
2.4.1 Lonza Group AG Details
2.4.2 Lonza Group AG Major Business
2.4.3 Lonza Group AG Non-Invasive Liquid Biopsy Product and Solutions
2.4.4 Lonza Group AG Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Lonza Group AG Recent Developments and Future Plans
2.5 MDxHealth
2.5.1 MDxHealth Details
2.5.2 MDxHealth Major Business
2.5.3 MDxHealth Non-Invasive Liquid Biopsy Product and Solutions
2.5.4 MDxHealth Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 MDxHealth Recent Developments and Future Plans
2.6 Merck KGaA
2.6.1 Merck KGaA Details
2.6.2 Merck KGaA Major Business
2.6.3 Merck KGaA Non-Invasive Liquid Biopsy Product and Solutions
2.6.4 Merck KGaA Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck KGaA Recent Developments and Future Plans
2.7 MutantDx
2.7.1 MutantDx Details
2.7.2 MutantDx Major Business
2.7.3 MutantDx Non-Invasive Liquid Biopsy Product and Solutions
2.7.4 MutantDx Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 MutantDx Recent Developments and Future Plans
2.8 Norgen Biotek Corp
2.8.1 Norgen Biotek Corp Details
2.8.2 Norgen Biotek Corp Major Business
2.8.3 Norgen Biotek Corp Non-Invasive Liquid Biopsy Product and Solutions
2.8.4 Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Norgen Biotek Corp Recent Developments and Future Plans
2.9 Nucleix
2.9.1 Nucleix Details
2.9.2 Nucleix Major Business
2.9.3 Nucleix Non-Invasive Liquid Biopsy Product and Solutions
2.9.4 Nucleix Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Nucleix Recent Developments and Future Plans
2.10 Oasis Diagnostics Corporation
2.10.1 Oasis Diagnostics Corporation Details
2.10.2 Oasis Diagnostics Corporation Major Business
2.10.3 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.10.4 Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Oasis Diagnostics Corporation Recent Developments and Future Plans
2.11 OraSure Technologies
2.11.1 OraSure Technologies Details
2.11.2 OraSure Technologies Major Business
2.11.3 OraSure Technologies Non-Invasive Liquid Biopsy Product and Solutions
2.11.4 OraSure Technologies Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 OraSure Technologies Recent Developments and Future Plans
2.12 PerkinElmer
2.12.1 PerkinElmer Details
2.12.2 PerkinElmer Major Business
2.12.3 PerkinElmer Non-Invasive Liquid Biopsy Product and Solutions
2.12.4 PerkinElmer Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 PerkinElmer Recent Developments and Future Plans
2.13 Predicine
2.13.1 Predicine Details
2.13.2 Predicine Major Business
2.13.3 Predicine Non-Invasive Liquid Biopsy Product and Solutions
2.13.4 Predicine Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Predicine Recent Developments and Future Plans
2.14 Qiagen
2.14.1 Qiagen Details
2.14.2 Qiagen Major Business
2.14.3 Qiagen Non-Invasive Liquid Biopsy Product and Solutions
2.14.4 Qiagen Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Qiagen Recent Developments and Future Plans
2.15 Thermo Fisher Scientific
2.15.1 Thermo Fisher Scientific Details
2.15.2 Thermo Fisher Scientific Major Business
2.15.3 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product and Solutions
2.15.4 Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.16 Zymo Research Corporation
2.16.1 Zymo Research Corporation Details
2.16.2 Zymo Research Corporation Major Business
2.16.3 Zymo Research Corporation Non-Invasive Liquid Biopsy Product and Solutions
2.16.4 Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Zymo Research Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-Invasive Liquid Biopsy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Non-Invasive Liquid Biopsy Players Market Share
3.2.2 Top 10 Non-Invasive Liquid Biopsy Players Market Share
3.2.3 Market Competition Trend
3.3 Non-Invasive Liquid Biopsy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Non-Invasive Liquid Biopsy Revenue and Market Share by Type (2016-2021)
4.2 Global Non-Invasive Liquid Biopsy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Non-Invasive Liquid Biopsy Revenue Market Share by Application (2016-2021)
5.2 Non-Invasive Liquid Biopsy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Non-Invasive Liquid Biopsy Revenue by Type (2016-2026)
6.2 North America Non-Invasive Liquid Biopsy Revenue by Application (2016-2026)
6.3 North America Non-Invasive Liquid Biopsy Market Size by Country
6.3.1 North America Non-Invasive Liquid Biopsy Revenue by Country (2016-2026)
6.3.2 United States Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
6.3.3 Canada Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
6.3.4 Mexico Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Non-Invasive Liquid Biopsy Revenue by Type (2016-2026)
7.2 Europe Non-Invasive Liquid Biopsy Revenue by Application (2016-2026)
7.3 Europe Non-Invasive Liquid Biopsy Market Size by Country
7.3.1 Europe Non-Invasive Liquid Biopsy Revenue by Country (2016-2026)
7.3.2 Germany Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
7.3.3 France Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
7.3.5 Russia Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
7.3.6 Italy Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Type (2016-2026)
8.2 Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Application (2016-2026)
8.3 Asia-Pacific Non-Invasive Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Region (2016-2026)
8.3.2 China Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
8.3.3 Japan Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
8.3.4 South Korea Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
8.3.5 India Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
8.3.7 Australia Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Non-Invasive Liquid Biopsy Revenue by Type (2016-2026)
9.2 South America Non-Invasive Liquid Biopsy Revenue by Application (2016-2026)
9.3 South America Non-Invasive Liquid Biopsy Market Size by Country
9.3.1 South America Non-Invasive Liquid Biopsy Revenue by Country (2016-2026)
9.3.2 Brazil Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
9.3.3 Argentina Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Type (2016-2026)
10.2 Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Application (2016-2026)
10.3 Middle East & Africa Non-Invasive Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Country (2016-2026)
10.3.2 Turkey Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
10.3.4 UAE Non-Invasive Liquid Biopsy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Non-Invasive Liquid Biopsy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Non-Invasive Liquid Biopsy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Non-Invasive Liquid Biopsy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Non-Invasive Liquid Biopsy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Non-Invasive Liquid Biopsy Revenue Market Share by Region (2021-2026)
Table 6. Bio-Techne Corporate Information, Head Office, and Major Competitors
Table 7. Bio-Techne Major Business
Table 8. Bio-Techne Non-Invasive Liquid Biopsy Product and Solutions
Table 9. Bio-Techne Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Endress+Hauser Corporate Information, Head Office, and Major Competitors
Table 11. Endress+Hauser Major Business
Table 12. Endress+Hauser Non-Invasive Liquid Biopsy Product and Solutions
Table 13. Endress+Hauser Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Exact Sciences Corporation Corporate Information, Head Office, and Major Competitors
Table 15. Exact Sciences Corporation Major Business
Table 16. Exact Sciences Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 17. Exact Sciences Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Lonza Group AG Corporate Information, Head Office, and Major Competitors
Table 19. Lonza Group AG Major Business
Table 20. Lonza Group AG Non-Invasive Liquid Biopsy Product and Solutions
Table 21. Lonza Group AG Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. MDxHealth Corporate Information, Head Office, and Major Competitors
Table 23. MDxHealth Major Business
Table 24. MDxHealth Non-Invasive Liquid Biopsy Product and Solutions
Table 25. MDxHealth Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 27. Merck KGaA Major Business
Table 28. Merck KGaA Non-Invasive Liquid Biopsy Product and Solutions
Table 29. Merck KGaA Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. MutantDx Corporate Information, Head Office, and Major Competitors
Table 31. MutantDx Major Business
Table 32. MutantDx Non-Invasive Liquid Biopsy Product and Solutions
Table 33. MutantDx Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Norgen Biotek Corp Corporate Information, Head Office, and Major Competitors
Table 35. Norgen Biotek Corp Major Business
Table 36. Norgen Biotek Corp Non-Invasive Liquid Biopsy Product and Solutions
Table 37. Norgen Biotek Corp Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Nucleix Corporate Information, Head Office, and Major Competitors
Table 39. Nucleix Major Business
Table 40. Nucleix Non-Invasive Liquid Biopsy Product and Solutions
Table 41. Nucleix Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Oasis Diagnostics Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Oasis Diagnostics Corporation Major Business
Table 44. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 45. Oasis Diagnostics Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. OraSure Technologies Corporate Information, Head Office, and Major Competitors
Table 47. OraSure Technologies Major Business
Table 48. OraSure Technologies Non-Invasive Liquid Biopsy Product and Solutions
Table 49. OraSure Technologies Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 51. PerkinElmer Major Business
Table 52. PerkinElmer Non-Invasive Liquid Biopsy Product and Solutions
Table 53. PerkinElmer Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Predicine Corporate Information, Head Office, and Major Competitors
Table 55. Predicine Major Business
Table 56. Predicine Non-Invasive Liquid Biopsy Product and Solutions
Table 57. Predicine Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Qiagen Corporate Information, Head Office, and Major Competitors
Table 59. Qiagen Major Business
Table 60. Qiagen Non-Invasive Liquid Biopsy Product and Solutions
Table 61. Qiagen Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 63. Thermo Fisher Scientific Major Business
Table 64. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Product and Solutions
Table 65. Thermo Fisher Scientific Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Zymo Research Corporation Corporate Information, Head Office, and Major Competitors
Table 67. Zymo Research Corporation Major Business
Table 68. Zymo Research Corporation Non-Invasive Liquid Biopsy Product and Solutions
Table 69. Zymo Research Corporation Non-Invasive Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Non-Invasive Liquid Biopsy Revenue (USD Million) by Players (2019-2021)
Table 71. Global Non-Invasive Liquid Biopsy Revenue Share by Players (2019-2021)
Table 72. Breakdown of Non-Invasive Liquid Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Non-Invasive Liquid Biopsy Players Head Office, Products and Services Provided
Table 74. Non-Invasive Liquid Biopsy Mergers & Acquisitions in the Past Five Years
Table 75. Non-Invasive Liquid Biopsy New Entrants and Expansion Plans
Table 76. Global Non-Invasive Liquid Biopsy Revenue (USD Million) by Type (2016-2021)
Table 77. Global Non-Invasive Liquid Biopsy Revenue Share by Type (2016-2021)
Table 78. Global Non-Invasive Liquid Biopsy Revenue Forecast by Type (2021-2026)
Table 79. Global Non-Invasive Liquid Biopsy Revenue by Application (2016-2021)
Table 80. Global Non-Invasive Liquid Biopsy Revenue Forecast by Application (2021-2026)
Table 81. North America Non-Invasive Liquid Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Non-Invasive Liquid Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Non-Invasive Liquid Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Non-Invasive Liquid Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Non-Invasive Liquid Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Non-Invasive Liquid Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Non-Invasive Liquid Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Non-Invasive Liquid Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Non-Invasive Liquid Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Non-Invasive Liquid Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Non-Invasive Liquid Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Non-Invasive Liquid Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Non-Invasive Liquid Biopsy Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Non-Invasive Liquid Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Non-Invasive Liquid Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Non-Invasive Liquid Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Non-Invasive Liquid Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Non-Invasive Liquid Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Non-Invasive Liquid Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Non-Invasive Liquid Biopsy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Non-Invasive Liquid Biopsy Picture
Figure 2. Global Non-Invasive Liquid Biopsy Revenue Market Share by Type in 2020
Figure 3. Stool Test
Figure 4. Urine Test
Figure 5. Saliva Test
Figure 6. Others
Figure 7. Non-Invasive Liquid Biopsy Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Laboratory Picture
Figure 10. Others Picture
Figure 11. Global Non-Invasive Liquid Biopsy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Non-Invasive Liquid Biopsy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Non-Invasive Liquid Biopsy Revenue Market Share by Region (2016-2026)
Figure 14. Global Non-Invasive Liquid Biopsy Revenue Market Share by Region in 2020
Figure 15. North America Non-Invasive Liquid Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Non-Invasive Liquid Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Non-Invasive Liquid Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Non-Invasive Liquid Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Non-Invasive Liquid Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Non-Invasive Liquid Biopsy Market Drivers
Figure 21. Non-Invasive Liquid Biopsy Market Restraints
Figure 22. Non-Invasive Liquid Biopsy Market Trends
Figure 23. Bio-Techne Recent Developments and Future Plans
Figure 24. Endress+Hauser Recent Developments and Future Plans
Figure 25. Exact Sciences Corporation Recent Developments and Future Plans
Figure 26. Lonza Group AG Recent Developments and Future Plans
Figure 27. MDxHealth Recent Developments and Future Plans
Figure 28. Merck KGaA Recent Developments and Future Plans
Figure 29. MutantDx Recent Developments and Future Plans
Figure 30. Norgen Biotek Corp Recent Developments and Future Plans
Figure 31. Nucleix Recent Developments and Future Plans
Figure 32. Oasis Diagnostics Corporation Recent Developments and Future Plans
Figure 33. OraSure Technologies Recent Developments and Future Plans
Figure 34. PerkinElmer Recent Developments and Future Plans
Figure 35. Predicine Recent Developments and Future Plans
Figure 36. Qiagen Recent Developments and Future Plans
Figure 37. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 38. Zymo Research Corporation Recent Developments and Future Plans
Figure 39. Global Non-Invasive Liquid Biopsy Revenue Share by Players in 2020
Figure 40. Non-Invasive Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Non-Invasive Liquid Biopsy Revenue Market Share in 2020
Figure 42. Global Top 10 Players Non-Invasive Liquid Biopsy Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Non-Invasive Liquid Biopsy Revenue Share by Type in 2020
Figure 45. Global Non-Invasive Liquid Biopsy Market Share Forecast by Type (2021-2026)
Figure 46. Global Non-Invasive Liquid Biopsy Revenue Share by Application in 2020
Figure 47. Global Non-Invasive Liquid Biopsy Market Share Forecast by Application (2021-2026)
Figure 48. North America Non-Invasive Liquid Biopsy Sales Market Share by Type (2016-2026)
Figure 49. North America Non-Invasive Liquid Biopsy Sales Market Share by Application (2016-2026)
Figure 50. North America Non-Invasive Liquid Biopsy Revenue Market Share by Country (2016-2026)
Figure 51. United States Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Non-Invasive Liquid Biopsy Sales Market Share by Type (2016-2026)
Figure 55. Europe Non-Invasive Liquid Biopsy Sales Market Share by Application (2016-2026)
Figure 56. Europe Non-Invasive Liquid Biopsy Revenue Market Share by Country (2016-2026)
Figure 57. Germany Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Non-Invasive Liquid Biopsy Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Non-Invasive Liquid Biopsy Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Non-Invasive Liquid Biopsy Revenue Market Share by Region (2016-2026)
Figure 65. China Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Non-Invasive Liquid Biopsy Sales Market Share by Type (2016-2026)
Figure 72. South America Non-Invasive Liquid Biopsy Sales Market Share by Application (2016-2026)
Figure 73. South America Non-Invasive Liquid Biopsy Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Non-Invasive Liquid Biopsy Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Non-Invasive Liquid Biopsy Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Non-Invasive Liquid Biopsy Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Non-Invasive Liquid Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
